One68 Global Capital’s OptiNose OPTN Stock Holding History

One68 Global Capital’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-693	Closed	-$20K	–	37
2023 Q1	$20K	Buy	+693	New	+$18.4K	0.03%	48

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

One68 Global Capital's OPTN Position: Q2 2023 in Review

One68 Global Capital sold out of OptiNose (OPTN) in Q2 2023, closing a stake of 693 shares — an estimated $20K sold.

One68 Global Capital first reported a position in OPTN in Q1 2023 and held it in 1 quarter. The position peaked at $20K in Q1 2023. 61 funds tracked by Wall St. Rank hold OPTN as of Q2 2023.

One68 Global Capital reported no remaining OptiNose position as of Q2 2023 after selling out during the quarter.
One68 Global Capital sold 693 OptiNose shares in Q2 2023, an estimated $20K.
One68 Global Capital first reported a position in OptiNose in Q1 2023 and held it in 1 quarter.
One68 Global Capital's OptiNose position peaked at $20K in Q1 2023.
61 funds tracked by Wall St. Rank held OptiNose as of Q2 2023.

Based on One68 Global Capital's 13F filing for Q2 2023, filed 14 Aug 2023.